US Patent Issued to CHAMBIO on Nov. 3 for "Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection- associated disorders" (Taiwanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,778,995, issued on Nov. 3, was assigned to CHAMBIO Co. LTD. (Taichung City, Taiwan).

"Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection- associated disorders" was invented by Meei-Yn Lin (Taichung City, Taiwan), Hung-Pin Chiu (Taichung City, Taiwan) and Yi-Heng Chiu (Taichung City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for preventing a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated disorder includes use of a composition containing live Bacillus coagulans CB85 which is deposited under the Budapest Treaty at the ...